摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-Pyridin-3-yl-8-azabicyclo[3.2.1]octane | 1203212-38-7

中文名称
——
中文别名
——
英文名称
3-Pyridin-3-yl-8-azabicyclo[3.2.1]octane
英文别名
——
3-Pyridin-3-yl-8-azabicyclo[3.2.1]octane化学式
CAS
1203212-38-7
化学式
C12H16N2
mdl
——
分子量
188.27
InChiKey
IVGNUXMVOBQSTP-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.6
  • 重原子数:
    14
  • 可旋转键数:
    1
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.58
  • 拓扑面积:
    24.9
  • 氢给体数:
    1
  • 氢受体数:
    2

文献信息

  • Urea derivatives of substituted nortropanes, medicaments containing such compounds and their use
    申请人:Eckhardt Matthias
    公开号:US20110275595A1
    公开(公告)日:2011-11-10
    The present invention relates to compounds defined by formula I wherein the groups R 1 , Y 1 to Y 4 , V, W, and X are defined as in claim 1 , possessing valuable pharmacological activity. Particularly the compounds are inhibitors of 11 β-hydroxysteroid dehydrogenase (HSD) 1 and thus are suitable for treatment and prevention of diseases which can be influenced by inhibition of this enzyme, such as metabolic diseases, in particular diabetes type 2, obesity, and dyslipidemia.
    本发明涉及由式I定义的化合物,其中R1,Y1至Y4,V,W和X基团的定义如权利要求书中所述,具有有价值的药理活性。特别是这些化合物是11β-羟基类固醇脱氢酶(HSD)1的抑制剂,因此适用于治疗和预防可以受到该酶抑制的疾病,例如代谢性疾病,特别是2型糖尿病、肥胖症和血脂异常。
  • Aryl- and Heteroarylcarbonyl derivatives of substituted nortropanes, medicaments containing such compounds and their use
    申请人:Eckhardt Matthias
    公开号:US20120115853A1
    公开(公告)日:2012-05-10
    The present invention relates to compounds defined by formula (I) wherein the groups R 1 and R 2 are defined as in claim 1 , possessing valuable pharmacological activity. Particularly the compounds are inhibitors of 11 β-hydroxysteroid dehydrogenase (HSD) 1 and thus are suitable for treatment and prevention of diseases which can be influenced by inhibition of this enzyme, such as metabolic diseases, in particular diabetes type 2, obesity, and dyslipidemia.
    本发明涉及公式(I)所定义的化合物,其中基团R1和R2如权利要求1所定义,具有有价值的药理活性。特别是,这些化合物是11β-羟类固醇脱氢酶(HSD)1的抑制剂,因此适用于治疗和预防可以受到该酶抑制影响的疾病,如代谢性疾病,特别是2型糖尿病、肥胖症和血脂异常。
  • 8-AZABICYCLO 3.2.1]OCTANE-, 8-AZABICYCLO 3.2.1]OCT-6-ENE-, 9-AZABICYCLO 3.3.1]NONANE-, 9-AZA-3-OXABICYCLO 3.3.1]NONANE- AND 9-AZA-3-THIABICYCLO 3.3.1]NONANE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS INSECTICIDES
    申请人:Syngenta Limited
    公开号:EP0944627B1
    公开(公告)日:2004-02-18
  • Aryl- and heteroarylcarbonyl derivatives of substituted nortropanes, medicaments containing such compounds and their use
    申请人:Boehringer Ingelheim International GmbH
    公开号:EP2318403B1
    公开(公告)日:2015-12-23
  • UREA DERIVATIVES OF SUBSTITUTED NORTROPANES, MEDICAMENTS CONTAINING SUCH COMPOUNDS AND THEIR USE
    申请人:Boehringer Ingelheim International GmbH
    公开号:EP2350068B1
    公开(公告)日:2017-08-30
查看更多